BSP:S1YK34 (USA)
Business Description
Stryker Corp
NAICS : 339112
SIC : 3841
2825 Airview Boulevard, Kalamazoo, MI, USA, 49002
Compare
Compare
Traded in other countries / regions
SYK.Austria
•
S1YK34.Brazil
•
SYK.Germany
•
SYK.Mexico
•
SYK.Switzerland
•
0R2S.UK
•
SYK.USA
Description
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.08 | |||||
| Equity-to-Asset | 0.44 | |||||
| Debt-to-Equity | 0.85 | |||||
| Debt-to-EBITDA | 3.7 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.88 | |||||
| Beneish M-Score | -2.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.8 | |||||
| 3-Year EBITDA Growth Rate | 3.7 | |||||
| 3-Year EPS without NRI Growth Rate | -17.7 | |||||
| 3-Year FCF Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | 7.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 8.82 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 7.26 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.77 | |||||
| 9-Day RSI | 63.77 | |||||
| 14-Day RSI | 60.64 | |||||
| 6-1 Month Momentum % | -28.89 | |||||
| 12-1 Month Momentum % | -23.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2 | |||||
| Quick Ratio | 1.15 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 199.63 | |||||
| Days Sales Outstanding | 60.83 | |||||
| Days Payable | 59.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.26 | |||||
| Dividend Payout Ratio | 0.5 | |||||
| 3-Year Dividend Growth Rate | 10.2 | |||||
| Forward Dividend Yield % | 1.26 | |||||
| 5-Year Yield-on-Cost % | 2.09 | |||||
| 3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.8 | |||||
| Operating Margin % | 15.04 | |||||
| Net Margin % | 11.79 | |||||
| ROE % | 14.12 | |||||
| ROA % | 5.95 | |||||
| ROIC % | 7.97 | |||||
| ROC (Joel Greenblatt) % | 48.15 | |||||
| ROCE % | 8.69 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 41.09 | |||||
| Forward PE Ratio | 23.75 | |||||
| PE Ratio without NRI | 41.09 | |||||
| Shiller PE Ratio | 44.5 | |||||
| Price-to-Owner-Earnings | 44.46 | |||||
| PEG Ratio | 11.41 | |||||
| PS Ratio | 4.84 | |||||
| PB Ratio | 5.39 | |||||
| Price-to-Free-Cash-Flow | 41.29 | |||||
| Price-to-Operating-Cash-Flow | 32.02 | |||||
| EV-to-EBIT | 36.46 | |||||
| EV-to-Forward-EBIT | 26.43 | |||||
| EV-to-EBITDA | 26.71 | |||||
| EV-to-Forward-EBITDA | 21.13 | |||||
| EV-to-Revenue | 5.48 | |||||
| EV-to-Forward-Revenue | 5.29 | |||||
| EV-to-FCF | 46.77 | |||||
| Price-to-Projected-FCF | 2.59 | |||||
| Price-to-DCF (Earnings Based) | 2.35 | |||||
| Price-to-DCF (FCF Based) | 2.66 | |||||
| Price-to-Median-PS-Value | 1.07 | |||||
| Earnings Yield (Greenblatt) % | 2.74 | |||||
| Forward Rate of Return (Yacktman) % | 5.16 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 92,497.751 | ||
| EPS (TTM) (R$) | 7.167 | ||
| Beta | 0 | ||
| Volatility % | 21.42 | ||
| 14-Day RSI | 60.64 | ||
| 14-Day ATR (R$) | 3.015452 | ||
| 20-Day SMA (R$) | 275.661 | ||
| 12-1 Month Momentum % | -23.42 | ||
| 52-Week Range (R$) | 253.33 - 379.01 | ||
| Shares Outstanding (Mil) | 1,513.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Stryker Corp Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||